Skip to main content


Latest articles

23-10-2020 | Oncology | News | Article

Cabozantinib improves quality-adjusted survival in advanced RCC

Treatment with cabozantinib gives patients with advanced renal cell carcinoma significantly more time without disease progression and toxicity relative to treatment with sunitinib, CABOSUN trial data show.

23-10-2020 | Oncology | News | Article

FDA recommends nivolumab–ipilimumab for inoperable mesothelioma

Read more on this announcement here

22-10-2020 | Oncology | News | Article

Neoadjuvant dual immune-checkpoint blockade shows promise in UC

Cisplatin-ineligible patients with locally advanced or high-risk urothelial carcinoma could benefit from neoadjuvant treatment with a PD-1/PD-L1 inhibitor in combination with a CTLA-4 inhibitor, show two phase 1 studies published in Nature Medicine.

21-10-2020 | Oncology | Highlight | Article

Gene-based model may identify high-risk breast cancer patients

A prognostic model based on eight DNA repair-related genes may help identify women with breast cancer who are at high risk for death, Chinese researchers report.

20-10-2020 | Oncology | News | Article

Switch maintenance therapy not suitable for older NSCLC patients

Older patients with non-small-cell lung cancer who have not progressed on platinum-based doublet therapy do not gain an overall survival advantage if treated with switch maintenance therapy rather than observation, study findings show.

19-10-2020 | Oncology | News | Article

Olaparib recommended for BRCA-mutated metastatic CRPC

Click through to read this EMA update

Image Credits